UW23016
OPEN TO ACCRUAL
Phase II Liposomal Irinotecan w/ TAS102 & Bevacizumab for Patients w/ mCRC
UW23142
OPEN TO ACCRUAL
PII Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for Early Stage Anal Cancer
EA2222
OPEN TO ACCRUAL
Ph III Study of Systemic Tx +/- Hepatic Arterial Infusion for Unresectable Colorectal Liver Mets
NRGGI008
OPEN TO ACCRUAL
II/III Study of Colon Adjuvant Chemo Based on Eval of Residual Disease (CIRCULATE-NORTH AMERICA)
UW24051
OPEN TO ACCRUAL
Phase 1/2 Basket Study of MK-2870 in GI Cancers
UW22123
OPEN TO ACCRUAL
PH1 Study of Intra-anally Administered Lopinavir/Ritonavir in Subjects with HIV with AIN 2/3